Veterinary Vaccine Adjuvants Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Veterinary Vaccine Adjuvants Market is Segmented by Type (Alum and Calcium Salts, Oil Emulsion Adjuvants, Liposomes and Archaeosomes, Nanoparticles and Microparticles, and Other Types), Route of Administration (Oral, Subcutaneous, Intramuscular, and Other Routes of Administration), Animal Type (Livestock and Companion Animals), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Veterinary Vaccine Adjuvants Market Size

Veterinary Vaccine Adjuvants Market Summary
share button
Study Period: 2018-2028
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.4 %

Major Players

Veterinary Vaccine Adjuvants Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and it's growth?

Veterinary Vaccine Adjuvants Market Analysis

The veterinary vaccine adjuvant market is expected to register a CAGR of 6.4% over the forecast period.

The COVID-19 pandemic impacted the veterinary vaccine adjuvants market. It highlighted the adaptability and response of veterinary healthcare to an emerging infectious disease and its role in maintaining animal health and protecting human public health. The increasing adoption of companion animals has increased the demand for vaccines, thus positively impacting the market. For instance, according to the People's Dispensary for Sick Animals (PDSA) PAW report published in June 2021, 2.0 million people in the United Kingdom owned pets between March 2020 and May 2021. Similarly, as per the report published by Nederlandse Voedingsindustrie Gezelschapsdieren(NVG) in 2021, around 8.0% of Dutch households started keeping a pet during the pandemic, which was around 6.4% during 2020, and another 7.0% intended to keep a pet. Out of the 8.0% of households that took a pet into their home during the pandemic, 47.0% of the people chose a dog and 27.0% chose a cat. Thus, the market witnessed positive growth during the pandemic, and it is expected to maintain an upward trend over the forecast period.

The rising use of adjuvants in the vaccine, the increasing livestock population and their associated diseases, and the high incidence of various diseases are the major drivers for the market. The high incidence of various diseases is one of the key factors propelling the market's growth. For instance, as per the NCBI study published in September 2021, anemia is the most common condition in sow herds, especially during gestation. The condition occurs despite iron supplementation in feed and has been associated with an increased stillbirth rate. Similarly, as per the report published by the CDC in September 2021, Bovine Spongiform Encephalopathy (BSE) is one of the most prevalent chronic diseases among cattle in Canada. The report stated that the true prevalence of Bovine Spongiform Encephalopathy (BSE) in Canada was around 90.0%, which is higher than the prevalence of BSE in the United States (3.0-8.0 cases per million Canada and around 0.167 cases per million in the United States). As per the report published by the Government of Canada in April 2022, various avian species, turkeys, ducks/chickens, geese, and peafowls were infected by avian influenza in March 2022. The disease is spreading rapidly among all livestock species, owing to which the government is planning to adopt necessary steps to control the spread. Thus, such a high prevalence of diseases may propel the demand for veterinary vaccines adjuvants, which is expected to surge the market's growth over the forecast period.

The increasing livestock population and associated diseases are also boosting the market's growth. For instance, according to the report published by Statistics Canada in May 2022, farms in Canada reported 12.6 million total cattle in 2021, up from 12.5 million in the previous year. The percentage increase in milk cows, steers, and beef cows offset declines in heifers for slaughter, heifers for dairy herd replacement, heifers for beef herd replacement, and bulls. According to the research study published in the Infection Ecology & Epidemiology in September 2021, one of the most dangerous zoonotic diseases in the world is salmonellosis. Salmonella prevalence in animals and risk factors for increased transmission of salmonella spp. from animals to people were evident. Thus, owing to the increasing livestock population and associated diseases across the world, the market is expected to grow considerably over the forecast period.

However, high toxicity and side effects of adjuvants may hinder the market's growth over the forecast period.

Veterinary Vaccine Adjuvants Industry Segmentation

As per the scope of the report, vaccine adjuvants are substances that help to enhance the immune response of the vaccine. The adjuvants can be broadly classified into two types, the first one is vaccine delivery systems and the second one is immunostimulatory adjuvants. 

The veterinary vaccine adjuvants market is segmented by type (alum and calcium salts, oil emulsion adjuvants, liposomes and archaeosomes, nanoparticles and microparticles, and other types), route of administration (oral, subcutaneous, intramuscular, and other routes of administration), animal type (livestock and companion animals), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type
Alum and Calcium Salts
Oil Emulsion Adjuvants
Liposomes and Archaeosomes
Nanoparticles and Microparticles
Other Types
By Route of Administration
Other Routes of Administration
By Animal Type
Companion Animal
By Geography
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Veterinary Vaccine Adjuvants Market Trends

This section covers the major market trends shaping the Veterinary Vaccine Adjuvants Market according to our research experts:

Companion Animal Segment is Expected to Witness Considerable Growth During the Forecast Period

Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Owning a pet reduces blood pressure, serum triglycerides, and cholesterol levels, which consequently reduces the negative physiological impact of stress on the cardiovascular system. Deep interactions with pets have a positive impact on the release of oxytocin, one of the body’s “feel-good" neurotransmitters, which is ideally very important for social bonding. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth.

The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market. For instance, as per the report published by the European Pet Food Industry (FEDIAF) in 2021, in the European Union, around 140.0 million pets were reported (including Switzerland and Norway), of which around 64.0 million were dogs and 76.0 million were cats. It also reported that France and Germany constitute the highest pet population, i.e., around 22,600,000 and 26,400,000, respectively. The report also indicated that cats are the leading pets in the European Union. Lithuania and Estonia comprise an equal balance of dog and cat populations. Spain shows more preference toward dogs, and their pet population surpasses the cat population by 3.0 million. According to the survey conducted by the Dibevoand the Dutch Food Industry Companion Animals (NVG) in 2021, around 25.0% of households owned a cat and around 20.0% owned a dog. Aquarium fish secured the third-highest position in terms of preferred pets, with more than 7.0%. Almost half of all Dutch households own one or more pets. The total number of pets in the Netherlands is estimated to be almost 27.0 million. 

Vaccination is one of the essential requirements for companion animals. Thus, the increasing number of companion animals is expected to propel the demand for vaccines, thereby boosting the veterinary vaccine adjuvants market over the forecast period.

Veterinary Vaccine Adjuvants Market: Estimated Number of Companion Animals (in million), By Type of Animal, United States,2021

North America is Expected to Witness Significant Share During the Forecast Period

North America is expected to witness considerable growth over the forecast period, owing to the rising adoption of companion animals, increasing pet healthcare insurance, and improved veterinary healthcare infrastructure. With the rising trends of diseases in North America, the associated use of veterinary vaccines is also increasing. For instance, as per the report published by the Government of Canada in April 2022, Bovine Spongiform Encephalopathy (BSE) is a progressive, fatal disease of the nervous system of cattle. Health Canada and the Canadian Food Inspection Agency (CFIA) responded to such challenges by developing a comprehensive set of internationally recognized, science-based measures that effectively minimize the likelihood of exposure, amplification, and spread of BSE within the cattle population and protect consumers from associated risks to human health. According to the NCBI research study published in September 2021, chronic wasting disease (CWD) is a highly prevalent prion disease affecting both wild and farmed animals and stands out for being highly contagious, widespread, and persistent in the environment and facilitating the transmission of the disease. Thus, such a high incidence of diseases is expected to propel the market's growth in North America.

Key product launches, high concentration of market players or manufacturers, acquisitions and partnerships among major players, and increasing pet ownership in the United States are some of the factors driving the growth of the veterinary vaccine adjuvants market in the country. According to the National Pet Owners Survey 2021-2022, conducted by the American Pet Products Association (APPA), around 70.0% of US households own a pet, which equates to 90.5 million homes, including 45.3 million cats and 69.0 million dogs. The rising adoption of pets may drive the growth of the veterinary vaccine adjuvants market in the longer term. 

Veterinary Vaccine Adjuvants Market - Growth Rate by Region

Veterinary Vaccine Adjuvants Industry Overview

The veterinary vaccine adjuvant market is consolidated and consists of a few dominant players. In terms of market share, some of the major players currently dominate the market. With the rising prevalence of infectious diseases in animals, a few other smaller players are expected to enter the market in the coming years. Some of the major players in the market are SEPPIC, SPI Pharma, Bioveta AS, Croda Internation PLC, and Zoetis.

Veterinary Vaccine Adjuvants Market Leaders


  2. SPI Pharma

  3. Bioveta AS

  4. Croda International PLC

  5. Merck & Co., Inc.

*Disclaimer: Major Players sorted in no particular order

Veterinary Vaccine Adjuvants Market Concentration

Veterinary Vaccine Adjuvants Market News

  • In December 2022, Evonik launched non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene is the first known amaranth oil-derived squalene for use in adjuvants in parenteral dosage forms.
  • In June 2022, ICAR-NRC launched animal vaccines and other diagnostic kits. The vaccine contains inactivated SARS-CoV-2 (Delta) antigen with Alhydrogel as an adjuvant. It is safe for dogs, lions, leopards, mice, and rabbits.

Veterinary Vaccine Adjuvants Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Use of Adjuvants in Vaccines

      2. 4.2.2 Increasing Livestock Population and Associated Diseases

      3. 4.2.3 High Incidence of Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 High Toxicity and Side Effects of Adjuvants

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Type

      1. 5.1.1 Alum and Calcium Salts

      2. 5.1.2 Oil Emulsion Adjuvants

      3. 5.1.3 Liposomes and Archaeosomes

      4. 5.1.4 Nanoparticles and Microparticles

      5. 5.1.5 Other Types

    2. 5.2 By Route of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Intramuscular

      3. 5.2.3 Other Routes of Administration

    3. 5.3 By Animal Type

      1. 5.3.1 Livestock

      2. 5.3.2 Companion Animal

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Bioveta AS

      2. 6.1.2 Croda International PLC

      3. 6.1.3 Merck & Co. Inc.

      4. 6.1.4 Phibro Animal Health Corporation

      5. 6.1.5 SEPPIC

      6. 6.1.6 SPI Pharma

      7. 6.1.7 Zoetis

      8. 6.1.8 Invivogen

      9. 6.1.9 OZ Biosciences

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Veterinary Vaccine Adjuvants Market Research FAQs

The Veterinary Vaccine Adjuvants Market is studied from 2018 - 2028.

The Veterinary Vaccine Adjuvants Market is growing at a CAGR of 6.4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2018-2028.

North America holds highest share in 2022.

SEPPIC, SPI Pharma, Bioveta AS, Croda International PLC, Merck & Co., Inc. are the major companies operating in Veterinary Vaccine Adjuvants Market.

Veterinary Vaccine Adjuvants Industry Report

Statistics for the 2023 Veterinary Vaccine Adjuvants market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Veterinary Vaccine Adjuvants analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!